دورية أكاديمية
أعرض في EDS

Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer.

التفاصيل البيبلوغرافية
العنوان: Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer.
المؤلفون: Smit KC; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Derksen JWG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., Beets GLO; Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, 6200 MD Maastricht, The Netherlands., Belt EJT; Department of Surgery, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, 3318 AT Dordrecht, The Netherlands., Berbée M; Department of Radiotherapy, Maastro Clinic, 6202 NA Maastricht, The Netherlands., Coene PPLO; Department of Surgery, Maasstad Hospital, Maasstadweg 21, 3079 DZ Rotterdam, The Netherlands., van Cruijsen H; Department of Medical Oncology, Antonius Hospital, 8600 BA Sneek, The Netherlands., Davidis MA; Department of Medical Oncology, Rivas, Banneweg 57, 4204 AA Gorinchem, The Netherlands., Dekker JWT; Department of Surgery, Reinier de Graaf Hospital, Reinier de Graafweg 5, 2600 GA Delft, The Netherlands., van Dodewaard-de Jong JM; Department of Medical Oncology, Meander Medical Center, Maatweg 3, 3813 TZ Amersfoort, The Netherlands., Haringhuizen AW; Department of Medical Oncology, Ziekenhuis Gelderse Vallei, 6710 HN Ede, The Netherlands., Helgason HH; Department of Medical Oncology, Haaglanden Medical Center, 2501 CK Den Haag, The Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, 1800 AM Alkmaar, The Netherlands., Hoekstra R; Department of Medical Oncology, Ziekenhuisgroep Twente, Zilvermeeuw 1, 7609 PP Hengelo, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands., IJzermans JNM; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 AD Rotterdam, The Netherlands., Janssen JJB; Department of Medical Oncology, Canisius Wilhelmina Hospital, 6500 GS Nijmegen, The Netherlands., Konsten JLM; Department of Surgery, Viecuri Hospital, Tegelseweg 210, 5912 BL Venlo, The Netherlands., Los M; Department of Medical Oncology, St. Antonius Hospital, 3430 EM Nieuwegein, The Netherlands., Mekenkamp LJM; Department of Medical Oncology, Medisch Spectrum Twente, 7500 KA Enschede, The Netherlands., Nieboer P; Department of Medical Oncology, Wilhelmina Hospital, 9400 RA Assen, The Netherlands., Peeters KCMJ; Department of Surgery, Leiden University Medical Center, University of Leiden, Postzone K6-39 Albinusdreef 2, 2300 RC Leiden, The Netherlands., Peters NAJB; Department of Medical Oncology, Sint Jans Hospital, Vogelsbleek 5, 6001 BE Weert, The Netherlands., Pruijt HJFM; Department of Medical Oncology, Jeroen Bosch Hospital, 5200 ME Den Bosch, The Netherlands., Quarles van Ufford-Mannesse P; Department of Medical Oncology, Haga Hospital, Els Borst-Eilersplein 275, 2545 AA Den Haag, The Netherlands., Rietbroek RC; Department of Medical Oncology, Rode Kruis Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands., Schiphorst AHW; Department of Surgery, Diakonessenhuis Hospital, Bosboomstraat 1, 3582 KE Utrecht, The Netherlands., Schouten van der Velden A; Department of Surgery, St. Jansdal Hospital, Wethouder Jansenlaan 90, 3844 DG Harderwijk, The Netherlands., Schrauwen RWM; Department of Gastroenterology and Hepatology, Bernhoven Hospital, Nistelrodeseweg 10, 5406 PT Uden, The Netherlands., Sie MPS; Department of Medical Oncology, ZorgSaam Hospital, Wielingenlaan 2, 4535 PA Terneuzen, The Netherlands., Sommeijer DW; Department of Medical Oncology, Academisch Medisch Centrum, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Department of Medical Oncology, Flevo Hospital, Hospitaalweg 1, 1315 RA Almere, The Netherlands., Sonneveld DJA; Department of Surgery, Dijklander Hospital, Waterlandlaan 250, 1441 RN Purmerend, The Netherlands., Stockmann HBAC; Department of Surgery, Spaarne Hospital, 2000 AK Haarlem, The Netherlands., Tent M; Department of Medical Oncology, Treant Hospital, 7800 RA Emmen, The Netherlands., Terheggen F; Department of Medical Oncology, Bravis Hospital, Boerhaavelaan 25, 4708 AE Roosendaal, The Netherlands., Tjin-A-Ton MLR; Department of Medical Oncology, Rivierenland Hospital, 4000 HA Tiel, The Netherlands., Valkenburg-van Iersel L; Department of Medical Oncology, Maastricht University Medical Center, 6202 NA Maastricht, The Netherlands., van der Velden AMT; Department of Medical Oncology, Tergooi Hospital, Van Riebeeckweg 212, 1213 XZ Hilversum, The Netherlands., Vles WJ; Department of Surgery, Ikazia Hospital, Montessoriweg 1, 3083 AN Rotterdam, The Netherlands., van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Postus 9555, 6800 TA Arnhem, The Netherlands., Wegdam JA; Department of Surgery, Elkerliek Hospital, Wesselmanlaan 25, 5707 HA Helmond, The Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Center, University of Nijmegen, 6500 HB Nijmegen, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., On Behalf Of The Plcrc Study Group
المصدر: Cancers [Cancers (Basel)] 2022 Feb 16; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 16.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مستخلص: Regular physical activity (PA) is associated with improved overall survival (OS) in stage I-III colorectal cancer (CRC) patients. This association is less defined in patients with metastatic CRC (mCRC). We therefore conducted a study in mCRC patients participating in the Prospective Dutch Colorectal Cancer cohort. PA was assessed with the validated SQUASH questionnaire, filled-in within a maximum of 60 days after diagnosis of mCRC. PA was quantified by calculating Metabolic Equivalent Task (MET) hours per week. American College of Sports and Medicine (ACSM) PA guideline adherence, tertiles of moderate to vigorous PA (MVPA), and sport and leisure time MVPA (MVPA-SL) were assessed as well. Vital status was obtained from the municipal population registry. Cox proportional-hazards models were used to study the association between PA determinants and all-cause mortality adjusted for prognostic patient and treatment-related factors. In total, 293 mCRC patients (mean age 62.9 ± 10.6 years, 67% male) were included in the analysis. Compared to low levels, moderate and high levels of MET-hours were significantly associated with longer OS (fully adjusted hazard ratios: 0.491, (95% CI 0.299-0.807, p value = 0.005) and 0.485 (95% CI 0.303-0.778, p value = 0.003), respectively), as were high levels of MVPA (0.476 (95% CI 0.278-0.816, p value = 0.007)) and MVPA-SL (0.389 (95% CI 0.224-0.677, p value < 0.001)), and adherence to ACSM PA guidelines compared to non-adherence (0.629 (95% CI 0.412-0.961, p value = 0.032)). The present study provides evidence that higher PA levels at diagnosis of mCRC are associated with longer OS.
References: Cancer Causes Control. 2013 Jun;24(6):1207-22. (PMID: 23563998)
Int J Epidemiol. 1994 Oct;23(5):991-9. (PMID: 7860180)
J Clin Oncol. 2006 Aug 1;24(22):3527-34. (PMID: 16822844)
Cancers (Basel). 2021 Sep 25;13(19):. (PMID: 34638290)
Int J Cancer. 2013 Oct 15;133(8):1905-13. (PMID: 23580314)
Int J Behav Nutr Phys Act. 2018 Jun 25;15(1):58. (PMID: 29940977)
Gastroenterol Res Pract. 2013;2013:340851. (PMID: 24222762)
J Clin Epidemiol. 2003 Dec;56(12):1163-9. (PMID: 14680666)
Acta Oncol. 2016 Nov;55(11):1273-1280. (PMID: 27560599)
J Clin Oncol. 2019 Oct 10;37(29):2620-2631. (PMID: 31408415)
Ann Oncol. 2014 Jul;25(7):1293-1311. (PMID: 24644304)
Sci Rep. 2021 Feb 16;11(1):3923. (PMID: 33594104)
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81. (PMID: 21681120)
J Pain Symptom Manage. 2013 May;45(5):811-21. (PMID: 23017624)
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. (PMID: 31626055)
Public Health Nutr. 2002 Dec;5(6B):1163-76. (PMID: 12639225)
Gut. 2006 Jan;55(1):62-7. (PMID: 15972299)
Clin Colorectal Cancer. 2013 Dec;12(4):233-8. (PMID: 24035029)
J Clin Oncol. 2016 Jan 10;34(2):144-50. (PMID: 26503203)
J Natl Cancer Inst. 2012 Jun 6;104(11):815-40. (PMID: 22570317)
Br J Cancer. 2011 Nov 8;105 Suppl 1:S52-73. (PMID: 22048034)
CA Cancer J Clin. 2006 Nov-Dec;56(6):323-53. (PMID: 17135691)
Int J Behav Nutr Phys Act. 2008 Jun 02;5:33. (PMID: 18513450)
Br J Cancer. 2013 Aug 6;109(3):814-22. (PMID: 23787918)
Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1130-7. (PMID: 25976417)
Int J Cancer. 2017 May 1;140(9):1985-1997. (PMID: 28120416)
Eur J Cancer Prev. 2013 Nov;22(6):492-505. (PMID: 23591454)
Support Care Cancer. 2017 Oct;25(10):3031-3050. (PMID: 28741176)
J Clin Oncol. 2015 Jun 10;33(17):1918-27. (PMID: 25918291)
BMC Cancer. 2017 Oct 25;17(1):701. (PMID: 29070017)
PLoS One. 2013;8(1):e53916. (PMID: 23349764)
معلومات مُعتمدة: 162135 Regio Deal Foodvalley
فهرسة مساهمة: Keywords: all-cause mortality; metastatic colorectal cancer; physical activity; survival
تواريخ الأحداث: Date Created: 20220225 Latest Revision: 20220301
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC8870120
DOI: 10.3390/cancers14041001
PMID: 35205748
قاعدة البيانات: MEDLINE
الوصف
تدمد:2072-6694
DOI:10.3390/cancers14041001